Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Neurosciences|February 28, 2002
Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiencyJianxue Li, Marc R Pelletier, Jose-Luis Perez Velazquez, et al.
Advances in Experimental Medicine and Biology|May 8, 2002
Neuroprotective strategies in epilepsyPeter L Carlen, Marc R Pelletier, Aviv Ouanounou, et al.
Journal of Neurochemistry|July 16, 2003
Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expressionMarina Samoilova, Jianxue Li, Marc R Pelletier, et al.
Journal of Forensic Sciences|July 25, 2013
A review of alcohol-impaired driving: the role of blood alcohol concentration and complexity of the driving taskTeri L Martin, Patricia A M Solbeck, Daryl J Mayers, et al.
Cancer Research Communications|June 9, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World DataLang Ho Lee, Xin Xu, Thanos Mourikis, et al.
Cancer Immunology Research|September 21, 2022
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ MalignanciesFilip Janku, Sae-Won Han, Toshihiko Doi, et al.
Cancer Research Communications|March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N TrialsBenjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
Cancer Immunology Research|April 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune ResponsesRohan Diwanji, Neil A O'Brien, Jiyoung E Choi, et al.
Cancer Discovery|April 26, 2013
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitorsErick J Morris, Sharda Jha, Clifford R Restaino, et al.
Cancer Immunology Research|July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the TumorPaul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Pageof 1